Skip to main content

Advertisement

SpringerLink
Log in

Acute tumoral calcinosis due to severe hyperphosphatemia in a maintenance hemodialysis patient

  • Case report
  • Published:
CEN Case Reports Aims and scope Submit manuscript

Abstract

We report the case of a maintenance hemodialysis patient with severe hyperphosphatemia (26.6 mg/dL) who developed acute tumoral calcinosis. The patient started receiving maintenance hemodialysis after being diagnosed with type 2 diabetes mellitus. The patient’s phosphate levels suddenly increased. He had not taken the prescribed phosphate binders for the past 5 years. He noticed swelling of the palmar aspects of his right thumb, which was diagnosed as tumoral calcinosis. His serum phosphate level reached 26.6 mg/dL. He started taking medication to lower his serum phosphate levels. The patient had a long history of eating convenience foods. As food additives in convenience foods could be a major source of phosphate, the patient corrected this habit by replacing convenience foods with special foods for dialysis patients. His symptoms improved along with the decrease in his serum phosphate levels. The main reason for the abrupt decrease in phosphate levels could be the correction of his dietary habits. Therefore, phosphate levels in processed foods should be carefully considered in dialysis patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. http://www.prayon.com/en/our-activities/products/food-applications.php. Accessed 17 June 2016.

  2. Daugirdas JT, Finn WF, Emmett M, Chertow GM, Frequent Hemodialysis Network Trial Group. The phosphate binder equivalent dose. Semin Dial. 2011;24:41–9.

    Article  PubMed  Google Scholar 

  3. Shigematsu T. Phosphate balance and sevelemer hydrochrolide. JSDT. 2004;37:2055–6 (in Japanese).

    Google Scholar 

  4. Noori N, Sims JJ, Kopple JD, Shah A, Colman S, Shinaberger CS, Bross R, Mehrotra R, Kovesdy CP, Kalantar-Zadeh K. Organic and inorganic dietary phosphorus and its management in chronic kidney disease. Iran J Kidney Dis. 2010;4:89–100.

    PubMed  Google Scholar 

  5. Tanaka A, Nakajima Y (eds) (2006) Commercial food composition chart by the usual dose, 3rd edn. Ishiyaku Syuppan Co., Tokyo (in Japanese).

  6. Amann K. Media calcification and intima calcification are distinct entities in chronic kidney disease. Clin J Am Soc Nephrol. 2008;3:1599–605.

    Article  PubMed  Google Scholar 

  7. Nabeshima Y. Discovery of alpha-klotho unveiled new insights into calcium and phosphate homeostasis. Proc Jpn Acad Ser B Phys Biol Sci. 2009;85:125–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Ichikawa S, Austin AM, Gray AK, Allen MR, Econs MJ. Dietary phosphate restriction normalizes biochemical and skeletal abnormalities in a murine model of tumoral calcinosis. Endocrinology. 2011;152(12):4504–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000;87(7):E10–7.

    Article  CAS  PubMed  Google Scholar 

  10. Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME. Medial localization of mineralization-regulating proteins in association with Mönkeberg’s sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation. 1999;100:2168–76.

    Article  CAS  PubMed  Google Scholar 

  11. Giachelli CM. The emerging role of phosphate in vascular calcification. Kidney Int. 2009;75:890–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. London GM. Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function. J Am Soc Nephrol. 2003;14:S3050–9.

    Article  Google Scholar 

  13. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32:S112–9.

    Article  CAS  PubMed  Google Scholar 

  14. Calvo MS, Kumar R, Heath H. Persistently elevated parathyroid hormone secretion and action in young women after 4 weeks of ingesting phosphorus, low calcium diets. J Clin Endocrinol Metab. 1990;70:1334–40.

    Article  CAS  PubMed  Google Scholar 

  15. Sullivan CM, Leon JB, Sehgal AR. Phosphorus-containing food additives and the accuracy of nutrient databases: implications for renal patients. J Ren Nutr. 2007;17:350–4.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Sherman RA, Mehta O. Dietary phosphorus restriction in dialysis patients: potential impact of processed meat, poultry, and fish products as protein sources. Am J Kidney Dis. 2009;54:18–23.

    Article  CAS  PubMed  Google Scholar 

  17. Kemi VE, Rita HJ, Kärkkäinen MU, Viljakainen HT, Laaksonen MM, Outila TA, Lamberg-Allardt CJ. Habitual high phosphorus intakes and foods with phosphate additives negatively affect serum parathyroid hormone concentration: a cross-sectional study on healthy premenopausal women. Public Health Nutr. 2009;12:1885–92.

    Article  PubMed  Google Scholar 

  18. Kalantar-Zadeh K, Gutekunst L, Mehrotra R, Kovesdy CP, Bross R, Shinaberger CS, Noori N, Hirschberg R, Benner D, Nissenson AR, Kopple JD. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010;5:519–30.

    Article  CAS  PubMed  Google Scholar 

  19. Uribarri J, Calvo MS. Hidden sources of phosphorus in the typical American diet: does it matter in nephrology? Semin Dial. 2003;16:186–8.

    Article  PubMed  Google Scholar 

  20. Sherman RA. Dietary phosphate restriction and protein intake in dialysis patients: a misdirected focus. Semin Dial. 2007;20:16–8.

    Article  PubMed  Google Scholar 

  21. Shinaberger CS, Greenland S, Kopple JD, Van Wyck D, Mehrotra R, Kovesdy CP, Kalantar-Zadeh K. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr. 2008;88:1511–8.

    Article  CAS  PubMed  Google Scholar 

  22. Nishime K, Takamine A, Nakamura S, Kinjyo K, Saitou T. A case of calcific uremic arteriolopathy (calciphylaxis) involving a maintenance hemodialysis patients. JSDT. 2012;45:591–8 (in Japanese with English abstract).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, Department of Internal Medicine, Rakuwakai Otowakinen Hospital, 29-1 Koyamachinjyucho, Yamashina, Kyoto, 607-8116, Japan

    Keizo Nishime

  2. Division of Nephrology, Department of Internal Medicine, Saiseikai Shigaken Hospital, 2-4-1 Ohashi, Rittou, Shiga, 520-3046, Japan

    Hiroki Takahashi

Authors
  1. Keizo Nishime
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroki Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Keizo Nishime.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nishime, K., Takahashi, H. Acute tumoral calcinosis due to severe hyperphosphatemia in a maintenance hemodialysis patient. CEN Case Rep 5, 203–208 (2016). https://doi.org/10.1007/s13730-016-0225-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13730-016-0225-2

Keywords

Search

Navigation